Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jul 21, 2025

SELL
$75.55 - $92.52 $982 - $1,202
-13 Closed
0 $0
Q3 2022

Jul 21, 2025

BUY
$74.61 - $87.26 $969 - $1,134
13 New
13 $988,000
Q2 2022

Jul 21, 2025

SELL
$80.52 - $93.75 $259,193 - $301,781
-3,219 Closed
0 $0
Q1 2022

Jul 21, 2025

SELL
$80.11 - $90.62 $814,878 - $921,786
-10,172 Reduced 75.96%
3,219 $282 Million
Q4 2021

Jul 21, 2025

BUY
$79.7 - $88.13 $140,431 - $155,285
1,762 Added 15.15%
13,391 $1.17 Billion
Q3 2021

Jul 21, 2025

BUY
$81.78 - $95.14 $115,555 - $134,432
1,413 Added 13.83%
11,629 $951 Million
Q2 2021

Jul 21, 2025

SELL
$85.24 - $94.15 $3.46 Million - $3.82 Million
-40,614 Reduced 79.9%
10,216 $932 Million
Q1 2021

Jul 21, 2025

BUY
$83.5 - $98.47 $394,537 - $465,270
4,725 Added 10.25%
50,830 $4.34 Billion
Q4 2020

Jul 21, 2025

BUY
$78.07 - $94.43 $239,909 - $290,183
3,073 Added 7.14%
46,105 $4.35 Billion
Q3 2020

Jul 21, 2025

BUY
$82.14 - $91.0 $660,652 - $731,913
8,043 Added 22.99%
43,032 $3.74 Billion
Q2 2020

Jul 21, 2025

SELL
$80.93 - $91.1 $110,712 - $124,624
-1,368 Reduced 3.76%
34,989 $3.06 Billion
Q1 2020

Jul 21, 2025

BUY
$70.67 - $99.01 $390,098 - $546,535
5,520 Added 17.9%
36,357 $3 Billion
Q4 2019

Jul 21, 2025

BUY
$84.35 - $95.37 $387,082 - $437,652
4,589 Added 17.48%
30,837 $2.92 Billion
Q3 2019

Jul 21, 2025

BUY
$85.54 - $94.26 $403,150 - $444,247
4,713 Added 21.89%
26,248 $2.28 Billion
Q2 2019

Jul 21, 2025

BUY
$75.4 - $92.8 $363,578 - $447,481
4,822 Added 28.85%
21,535 $1.97 Billion
Q1 2019

Jul 21, 2025

BUY
$75.32 - $86.15 $199,748 - $228,469
2,652 Added 18.86%
16,713 $1.61 Billion
Q4 2018

Jul 21, 2025

BUY
$73.66 - $82.02 $293,461 - $326,767
3,984 Added 39.54%
14,061 $1.21 Billion
Q3 2018

Jul 21, 2025

BUY
$66.94 - $77.43 $674,554 - $780,262
10,077 New
10,077 $868 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $253B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Credential Qtrade Securities Inc. Portfolio

Follow Credential Qtrade Securities Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credential Qtrade Securities Inc., based on Form 13F filings with the SEC.

News

Stay updated on Credential Qtrade Securities Inc. with notifications on news.